IceCure Medical announces annual and special shareholder meeting
ICCM•IceCure Medical will hold a remote annual and special shareholder meeting on Nov. 2, 2026, with votes scheduled on auditor and director reappointments and equity awards.
1. Meeting proposals
Shareholders will vote on reappointing Deloitte Israel as independent auditor, with the board setting its remuneration until the next annual meeting, and on reappointing director Yang Huang for a three-year term through the 2029 annual meeting. Proposals also cover 404,901 RSUs for CEO Eyal Shamir, 230,577 RSUs for chairman Ron Mayron and 60,000 RSUs for Huang, contingent on his reappointment.
